Abstract:Background Microphthalmia-associated transcription factor (MITF) is a master regulator of melanogenesis and is mainly expressed in melanoma cells. MITF has also been reported to be expressed in non-pigmented cells, such as osteoclasts, mast cells, and B cells. However, the roles of MITF in immunosuppressive myeloid cells, including myeloid-derived suppressor cells (MDSCs), remain unclear. Here, we investigated the role of MITF in the differentiation process of MDSCs during tumor development. Methods In vitro-generated murine MDSCs and primary MDSCs from breast cancer-bearing mice or lung carcinoma-bearing mice were used to determine the expression level of MITF and the activity of MDSCs. Additionally, we investigated whether in vivo tumor growth can be differentially regulated by coinjection of MDSCs in which MITF expression is modulated by small molecules. Furthermore, the number of MITF + monocytic (MO)-MDSCs was examined in human tumor tissues or tumor-free lymph nodes by immunohistochemistry (IHC). Results The expression of MITF was strongly increased in MO-MDSCs from tumors of breast cancer-bearing mice compared with polymorphonuclear MDSCs. We found that MITF expression in MDSCs was markedly induced in the tumor microenvironment (TME) and related to the functional activity of MDSCs. MITF overexpression in myeloid cells increased the expression of MDSC activity markers and effectively inhibited T-cell proliferation compared with those of control MDSCs, whereas shRNA-mediated knockdown of MITF in myeloid cells altered the immunosuppressive function of MDSCs. Modulation of MITF expression by small molecules affected the differentiation and immunosuppressive function of MDSCs. While increased MITF expression in MDSCs promoted breast cancer progression and CD4 + or CD8 + T-cell dysfunction, decreased MITF expression in MDSCs suppressed tumor progression and enhanced T-cell activation. Furthermore, IHC staining of human tumor tissues revealed that MITF + MO-MDSCs are more frequently observed in tumor tissues than in tumor-free draining lymph nodes obtained from patients with cancer. Conclusions Our results indicate that MITF regulates the differentiation and function of MDSCs and can be a novel therapeutic target for modulating MDSC activity in immunosuppressive TMEs.

Emerging roles of MITF as a crucial regulator of immunity

Novel role of microphthalmia-associated transcription factor in modulating the differentiation and immunosuppressive functions of myeloid-derived suppressor cells

Expansion of Myeloid Immune Suppressor Cells in Tumor-bearing Host Directly Promotes Tumor Angiogenesis, Tumor Growth, and Metastasis

MITF: master regulator of melanocyte development and melanoma oncogene

The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?

MITF in melanoma: mechanisms behind its expression and activity

The underestimated role of the microphthalmia-associated transcription factor (MiTF) in normal and pathological haematopoiesis

MITF: A Stream Flowing for Pigment Cells

The MITF regulatory network in melanoma

Microphthalmia-Associated Transcription Factor in Senescence and Age-Related Diseases

MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species

MITF reprograms the extracellular matrix and focal adhesion in melanoma

Novel mechanisms of MITF regulation identified in a mouse suppressor screen

Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma

MITF induces escape from innate immunity in melanoma

MITF—the first 25 years

Mitf regulates gene expression networks implicated in B cell homeostasis, germinal center responses, and tolerance

Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation

The Role of MITF Phosphorylation Sites During Coat Color and Eye Development in Mice Analyzed by Bacterial Artificial Chromosome Transgene Rescue

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

Mitf-Mdel, a Novel Melanocyte/melanoma-Specific Isoform of Microphthalmia-Associated Transcription Factor-M, As a Candidate Biomarker for Melanoma